A Multiple-Model-Informed Drug-Development Approach for Optimal Regimen Selection of an Oncolytic Virus in Combination With Pembrolizumab.
Yamada A, Choules MP, Brightman FA, Takeshita S, Nakao S, Amino N, Nakayama T, Takeuchi M, Komatsu K, Ortega F, Mistry H, Orrell D, Chassagnole C, Bonate PL.
Yamada A, et al. Among authors: nakayama t.
CPT Pharmacometrics Syst Pharmacol. 2025 Jan 8. doi: 10.1002/psp4.13297. Online ahead of print.
CPT Pharmacometrics Syst Pharmacol. 2025.
PMID: 39776360
Free article.